Author pages are created from data sourced from our academic publisher partnerships and public sources.
Outcomes of kidney transplantation in HIV-infected recipients.
- P. Stock, B. Barin, +18 authors M. Roland
- The New England journal of medicine
- 18 November 2010
BACKGROUND The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood. METHODS We undertook a prospective,… Expand
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.
BACKGROUND There are few data on the epidemiology and outcomes of influenza infection in recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic influenza A H1N1 and… Expand
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
- N. Terrault, M. Roland, +22 authors P. Stock
- Liver transplantation : official publication of…
- 1 June 2012
Hepatitis C virus (HCV) is a controversial indication for liver transplantation (LT) in human immunodeficiency virus (HIV)–infected patients because of reportedly poor outcomes. This prospective,… Expand
Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
BACKGROUND Enterococcus faecium has received increased attention, primarily due to the emergence of vancomycin resistance. The purpose of this investigation was to study the epidemiological… Expand
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.
- N. Singh, B. Alexander, +24 authors S. Husain
- Biology, Medicine
- The Journal of infectious diseases
- 1 March 2007
Variables influencing the risk of dissemination and outcome of Cryptococcus neoformans infection were assessed in 111 organ transplant recipients with cryptococcosis in a prospective, multicenter,… Expand
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
Summary:Voriconazole, a new antifungal agent, is increasingly being used after HSCT. The hepatic cytochrome P450 isoenzyme 2C19 plays a significant role in voriconazole metabolism. As CYP2C19… Expand
Use of the QuantiFERON‐TB Gold interferon‐gamma release assay for screening transplant candidates: a single‐center retrospective study
- N. Theodoropoulos, F. Lanternier, +5 authors M. Ison
- Transplant infectious disease : an official…
- 1 February 2012
N. Theodoropoulos, F. Lanternier, J. Rassiwala, G. McNatt, L. Preczewski, E. DeMayo, V. Stosor, M.G. Ison. Use of the QuantiFERON‐TB Gold interferon‐gamma release assay for screening transplant… Expand
Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.
OBJECTIVE To determine the recovery of vancomycin-resistant enterococci (VRE) on fingertips, gloved fingertips, and environmental surfaces commonly encountered in the healthcare setting, and to… Expand
In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant Enterococci
- G. Noskin, F. Siddiqui, V. Stosor, D. Hacek, L. Peterson
- Biology, Medicine
- Antimicrobial Agents and Chemotherapy
- 1 August 1999
ABSTRACT The emergence of resistance in gram-positive bacteria has necessitated a search for new antimicrobial agents. Linezolid is an oxazolidinone, a new class of antibacterial agents with enhanced… Expand